Xenon Ophthalmics
Belleville, US · Founded 2019 · Delaware corporation
Find your way into Xenon Ophthalmics
Sign up to see every warm intro you have to Xenon Ophthalmics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Xenon Ophthalmics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RG
Robert GilliganNamed on SEC filing
ZK
Zeshan KhanNamed on SEC filing
SS
Steve SusanibarNamed on SEC filing
BS
Bruce StarkNamed on SEC filing
MD
Michelle DeFossettNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3.3M disclosed across 1 of 2 rounds · 2019–2023
▶$3.3MraisedOct 2026 · 20 investors · BiotechnologyRule 506(b)
▶$3.3MraisedOct 2026 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Zeshan KhanExecutive Officer, Director
- Steve SusanibarExecutive Officer
- Robert GilliganDirector
- Bruce StarkPromoter
- David SingelynDirector
- Amount sold
- $3.3M
- Minimum investment
- $20K
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Xenon Ophthalmics raised?
- Xenon Ophthalmics has disclosed $3.3M raised across 1 of its 2 known rounds.
- Where is Xenon Ophthalmics headquartered?
- Xenon Ophthalmics is headquartered in Belleville, US.